Gland Pharma Limited
GLAND
Rang in Aktien
#3238
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Aktienkurs
$33.33
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$5.50B
Veränderung (1 Tag)
-0.68%
Veränderung (1 Jahr)
52.58%
Land
IN
Handel Gland Pharma Limited (GLAND)
Kategorie
Healthcare
P/S-Verhältnis für Gland Pharma Limited (GLAND)
P/S-Verhältnis zum October 2026 TTM: 7.47
Laut den neuesten Finanzberichten und dem Aktienkurs von Gland Pharma Limited beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 7.47. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 5.27.
P/S-Verlauf für Gland Pharma Limited von 2017 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 7.47 | 63.72% |
| 2025 | 4.56 | -13.61% |
| 2024 | 5.27 | -9.26% |
| 2023 | 5.81 | -52.56% |
| 2022 | 12.25 | 7.08% |
| 2021 | 11.44 | 4.38% |
| 2020 | 10.96 | -26.45% |
| 2019 | 14.91 | -20.73% |
| 2018 | 18.80 | -1.35% |
| 2017 | 19.06 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -5.46% |
IN
|
